Symbol Name ID |
Pygl
liver glycogen phosphorylase MGI:97829 |
Darker colors indicate more annotations |
Human Phenotypes | Hypercholesterolemia |
Hyperlipidemia |
Hypertriglyceridemia |
Elevated circulating hepatic transaminase concentration |
Hypoglycemia |
Postprandial hyperlactemia |
Intermittent lactic acidemia |
Increased hepatic glycogen content |
Proteinuria |
Ketosis |
Postexertional symptom exacerbation |
Disease(s) Associated with PYGL | |||||||||||
glycogen storage disease VI |
Mouse Phenotypes | abnormal homeostasis |
decreased fasting circulating glucose level |
hypoglycemia |
increased circulating ketone body level |
decreased circulating cholesterol level |
decreased circulating triglyceride level |
increased circulating alanine transaminase level |
increased circulating aspartate transaminase level |
increased liver glycogen level |
decreased hepatic glucose production |
abnormal enzyme/coenzyme activity |
|
Availability | Mouse Genotype | |||||||||||
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|